Peptide-Based HIV Vaccines
2 articles in this topic.
Peptide-Based HIV Vaccines
Enfuvirtide: The Peptide That Blocks HIV Entry
How enfuvirtide (T-20) became the first HIV fusion inhibitor, from the 1993 discovery of gp41-blocking peptides to FDA approval in 2003 and its legacy.
13 min read|Mar 25, 2026
Peptide-Based HIV Vaccines
Cyclotides and HIV: Plant Peptides That Attack Viral Membranes
Cyclotides are ultra-stable cyclic plant peptides that inhibit HIV by disrupting viral lipid envelopes. Review of anti-HIV activity, mechanisms, and drug design.
13 min read|Mar 21, 2026